10
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
activeNational Institutes of Health
91 days left
Why this scored 10
Cancer epidemiology secondary data analysis; no facility or infrastructure component.
Overview
PAR-25-096 · synopsis · CFDA 93.393, 93.121, 93.172, 93.866
Client matchesAI suggests · you decide
No client matches yet. Run matching to see which of PCC2K's clients could apply for this grant.